Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no user-facing content changes are indicated.
    Difference
    0.0%
    Check dated 2026-03-25T07:08:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor version update that does not modify content or features.
    Difference
    0.0%
    Check dated 2026-03-10T17:32:38.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T03:28:06.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed the old funding-status notice (formerly v3.4.0), updating the page's revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-09T22:43:48.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page, informing users that information may not be up to date and directing readers to cc.nih.gov and opm.gov for status updates.
    Difference
    0.1%
    Check dated 2026-02-02T19:52:34.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Glossary display option added and QC metadata updated to revision v3.4.0, with adjustments to FEAR Act data references.
    Difference
    0.1%
    Check dated 2026-01-26T16:00:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.